EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sarcopenia and outcomes after CRS ± HIPEC for gastric peritoneal metastases: no association with major morbidity and poorer survival in synchronous disease

Iliès El Boukili, Vahan Kepenekian, Pascal Rousset, Guillaume Passot, Bertrand Le Roy, Laurent Villeneuve, Olivier Glehen, Rémi Grange

European Journal of Surgical Oncology · 2026-11 · 52 (11) · 112102

DOI: 10.1016/j.ejso.2026.112102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2026-11. Verfasst von Iliès El Boukili und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive and Oncological Surgery, University Hospital of Saint-Étienne, Saint-Priest-en-Jarez, 42270, France; EA 3738 CICLY, Universit…. Hauptthemen laut MEDLINE: Sarcopenia, Peritoneal Neoplasms, Hyperthermic Intraperitoneal Chemotherapy, Stomach Neoplasms. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: We evaluated whether computed tomography (CT)-based body composition parameters predict outcomes after hyperthermic intraperitoneal chemotherapy (CRS ± HIPEC) for gastric peritoneal metastases (GPM). METHODS: A retrospective analysis of a prospectively maintained single-centre database included consecutive patients undergoing CRS ± HIPEC for GPM between January 2014 and December 2024. Skeletal muscle index (SMI), muscle radiodensity, and adipose tissue parameters were quantified on preoperative CT at the third lumbar vertebra. Sarcopenia was defined using validated sex-specific cut-offs. Postoperative complications, progression-free survival (PFS), and overall survival (OS) were analysed using multivariable regression and sensitivity analyses based on alternative sarcopenia definitions. RESULTS: Among 108 procedures performed in 106 included patients, 36 (33%) were sarcopenic. Major complications did not differ significantly (44% vs 39%; OR 1.26, 95% CI 0.56-2.83; p = 0.679), although moderate differences could not be excluded. In the overall cohort, neither PFS nor OS differed significantly according to sarcopenia status. However, among patients with synchronous GPM, sarcopenia was associated with shorter OS (median 10.2 vs 16.3 months; HR 1.85, 95% CI 1.05-3.25; p = 0.033), with a consistent but non-significant multivariable trend (p = 0.061). An adjusted interaction analysis supported effect modification according to disease timing (p for interaction = 0.043). Sensitivity analyses using four alternative sarcopenia definitions yielded consistent findings. CONCLUSION: Preoperative CT-defined sarcopenia identifies patients with synchronous GPM at higher risk of poor overall survival after CRS ± HIPEC without a detectable increase in postoperative morbidity. CT-based body composition may improve preoperative prognostic stratification and help identify candidates for future studies of nutritional optimisation or multimodal prehabilitation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaPeritoneal NeoplasmsHyperthermic Intraperitoneal ChemotherapyStomach NeoplasmsHumansMaleFemaleCytoreduction Surgical ProceduresRetrospective StudiesMiddle AgedTomography, X-Ray ComputedAgedBody CompositionPostoperative ComplicationsSurvival RateMuscle, Skeletal

Stichwörter der Autor:innen

CT-based body compositionCytoreductive surgeryGastric peritoneal metastasesHyperthermic intraperitoneal chemotherapySarcopenia

Autor:innen und Institutionen

  • Department of Digestive and Oncological Surgery, University Hospital of Saint-Étienne, Saint-Priest-en-Jarez, 42270, France; EA 3738 CICLY, Université Claude Bernard Lyon 1, Lyon, France. Electronic address: ilies.elbou…
  • Department of General Surgery and Surgical Oncology, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre-Bénite, 69495, France; EA 3738 CICLY, Université Claude Bernard Lyon 1, Lyon, France.
  • Department of Radiology, Hospices Civils de Lyon, Lyon Sud University Hospital, Université Claude Bernard Lyon 1, Pierre-Bénite, 69495, France; EA 3738 CICLY, Université Claude Bernard Lyon 1, Lyon, France.
  • Department of Digestive and Oncological Surgery, University Hospital of Saint-Étienne, Saint-Priest-en-Jarez, 42270, France; EA 3738 CICLY, Université Claude Bernard Lyon 1, Lyon, France.
  • Department of Public Health, Clinical Research and Epidemiology, Hospices Civils de Lyon, Lyon, France; EA 3738 CICLY, Université Claude Bernard Lyon 1, Lyon, France.
  • Department of Radiology, University Hospital of Saint-Étienne, 42270 Saint-Priest-en-Jarez, France; EA 3738 CICLY, Université Claude Bernard Lyon 1, Lyon, France.

Zitieren

APA

El Boukili, I., Kepenekian, V., Rousset, P., Passot, G., Le Roy, B., Villeneuve, L., Glehen, O., & Grange, R. (2026). Sarcopenia and outcomes after CRS ± HIPEC for gastric peritoneal metastases: no association with major morbidity and poorer survival in synchronous disease. European Journal of Surgical Oncology, 52(11), 112102. https://doi.org/10.1016/j.ejso.2026.112102

Vancouver

El Boukili I, Kepenekian V, Rousset P, Passot G, Le Roy B, Villeneuve L, et al. Sarcopenia and outcomes after CRS ± HIPEC for gastric peritoneal metastases: no association with major morbidity and poorer survival in synchronous disease. European Journal of Surgical Oncology. 2026;52(11):112102. doi:10.1016/j.ejso.2026.112102

BibTeX
@article{ElBoukili2026,
  author = {El Boukili, Iliès and Kepenekian, Vahan and Rousset, Pascal and Passot, Guillaume and Le Roy, Bertrand and Villeneuve, Laurent and Glehen, Olivier and Grange, Rémi},
  title = {Sarcopenia and outcomes after CRS ± HIPEC for gastric peritoneal metastases: no association with major morbidity and poorer survival in synchronous disease},
  journal = {European Journal of Surgical Oncology},
  year = {2026},
  volume = {52},
  number = {11},
  pages = {112102},
  doi = {10.1016/j.ejso.2026.112102}
}
Kostenlos starten →